FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer
Clinical trial NCT00646607 · COMPLETED
Trial details
- NCT number
- NCT00646607
- Sponsor
- Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2013-04-01
- Enrollment
- 3756
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.